<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>MissionIR - Seeking Alpha</title>
    <description>© seekingalpha.com. Use of this feed is limited to personal, non-commercial use and is governed by Seeking Alpha's Terms of Use (http://seekingalpha.com/page/terms-of-use). Publishing this feed for public or commercial use and/or misrepresentation by a third party is prohibited.</description>
    <author>
      <name>SeekingAlpha.com</name>
    </author>
    <link>http://seekingalpha.com/author/missionir</link>
    <item>
      <title>SEFE: Investing In The Newest Renewable Source Of Electricity</title>
      <link>http://seekingalpha.com/article/506511-sefe-investing-in-the-newest-renewable-source-of-electricity?source=feed</link>
      <guid isPermaLink="false">506511</guid>
      <content>
        <![CDATA[<p><em>Note: We have received monetary compensation to perform investor relations services for</em> <em>SEFE, Inc. Readers should be aware that this compensation may indicate a potential bias in the material presented. The information presented is provided for informational purposes only and is not to be treated as advice to make any specific investment. The content included in this article is based on factual information obtained from public filings and other sources. For our full disclaimer, please visit the link on our</em> <a href="http://seekingalpha.com/author/missionir"><em>profile</em></a><em>.</em></p><p>It's almost impossible to discuss green energy without talking about electricity. Not that electricity should be considered a source of energy. Electricity is generally better viewed as a convenient medium for carrying energy from one point to another, from an initial point of generation to a final point of use. But electricity, and its storage, plays a major role in most renewable energy models. From hydroelectricity, still the</p>]]>
      </content>
      <pubDate>Wed, 18 Apr 2012 09:21:59 -0400</pubDate>
      <author>MissionIR</author>
      <description>
        <![CDATA[<strong>By <a href="http://missionir.com/">MissionIR</a>:</strong><p><em>Note: We have received monetary compensation to perform investor relations services for</em> <em>SEFE, Inc. Readers should be aware that this compensation may indicate a potential bias in the material presented. The information presented is provided for informational purposes only and is not to be treated as advice to make any specific investment. The content included in this article is based on factual information obtained from public filings and other sources. For our full disclaimer, please visit the link on our</em> <a href="http://seekingalpha.com/author/missionir"><em>profile</em></a><em>.</em></p><p>It's almost impossible to discuss green energy without talking about electricity. Not that electricity should be considered a source of energy. Electricity is generally better viewed as a convenient medium for carrying energy from one point to another, from an initial point of generation to a final point of use. But electricity, and its storage, plays a major role in most renewable energy models. From hydroelectricity, still the</p><br/><a href='http://seekingalpha.com/article/506511-sefe-investing-in-the-newest-renewable-source-of-electricity?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/sefe.ob">SEFE.OB</category>
      <category type="author" link="http://seekingalpha.com/author/missionir">MissionIR</category>
    </item>
    <item>
      <title>A Cloudy Forecast</title>
      <link>http://seekingalpha.com/article/496281-a-cloudy-forecast?source=feed</link>
      <guid isPermaLink="false">496281</guid>
      <content>
        <![CDATA[<p><em>Note: We have received monetary compensation to perform investor relations services for</em> <em>GlobalWise Investments. Readers should be aware that this compensation may indicate a potential bias in the material presented. The information presented is provided for informational purposes only and is not to be treated as advice to make any specific investment. The content included in this article is based on factual information obtained from public filings and other sources. For our full disclaimer, please visit the link on our</em> <a href="http://seekingalpha.com/author/missionir"><em>profile</em></a><em>.</em></p><p>This year it is estimated that fully 80% of new commercial computer enterprise applications will have a <span>cloud-based offering. Whether this turns out to be true, when it comes to the future of information processing, virtually every forecast sees <span>clouds on the horizon in leading roles. It's a market seen as too disruptive to ignore, expected to top $200 billion in revenues before 2020. It threatens the status</span></span></p>]]>
      </content>
      <pubDate>Fri, 13 Apr 2012 11:23:27 -0400</pubDate>
      <author>MissionIR</author>
      <description>
        <![CDATA[<strong>By <a href="http://missionir.com/">MissionIR</a>:</strong><p><em>Note: We have received monetary compensation to perform investor relations services for</em> <em>GlobalWise Investments. Readers should be aware that this compensation may indicate a potential bias in the material presented. The information presented is provided for informational purposes only and is not to be treated as advice to make any specific investment. The content included in this article is based on factual information obtained from public filings and other sources. For our full disclaimer, please visit the link on our</em> <a href="http://seekingalpha.com/author/missionir"><em>profile</em></a><em>.</em></p><p>This year it is estimated that fully 80% of new commercial computer enterprise applications will have a <span>cloud-based offering. Whether this turns out to be true, when it comes to the future of information processing, virtually every forecast sees <span>clouds on the horizon in leading roles. It's a market seen as too disruptive to ignore, expected to top $200 billion in revenues before 2020. It threatens the status</span></span></p><br/><a href='http://seekingalpha.com/article/496281-a-cloudy-forecast?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/aapl">AAPL</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/amzn">AMZN</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/bvsn">BVSN</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/crm">CRM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/goog">GOOG</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ibm">IBM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/sap">SAP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/orcl">ORCL</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ebay">EBAY</category>
      <category type="author" link="http://seekingalpha.com/author/missionir">MissionIR</category>
    </item>
    <item>
      <title>AdCare Health And The Art Of The Turnaround</title>
      <link>http://seekingalpha.com/article/416831-adcare-health-and-the-art-of-the-turnaround?source=feed</link>
      <guid isPermaLink="false">416831</guid>
      <content>
        <![CDATA[<p><em>Note: We have received monetary compensation to perform investor relations services for</em> <em>AdCare Health Systems (<a href='http://seekingalpha.com/symbol/adk' title='Adcare Health Systems Inc'>ADK</a>)</em><em>. Readers should be aware that this compensation may indicate a potential bias in the material presented. The information presented is provided for informational purposes only and is not to be treated as advice to make any specific investment. The content included in this article is based on factual information obtained from public filings and other sources. For our full disclaimer, please visit the link on our</em> <a href="http://seekingalpha.com/author/missionir"><em>profile</em></a><em>.</em></p> <p>Few investment opportunities are sweeter than a turnaround, where the value of a company is increased, sometimes dramatically, through the measured application of superior operational procedures, technologies, or marketing approaches. Usually this involves a single company bringing in new management to make the company more efficient or perhaps point the company in a totally new direction. With big companies, a turnaround can take years, even</p>        ]]>
      </content>
      <pubDate>Wed, 07 Mar 2012 07:50:11 -0500</pubDate>
      <author>MissionIR</author>
      <description>
        <![CDATA[<strong>By <a href="http://missionir.com/">MissionIR</a>:</strong><p><em>Note: We have received monetary compensation to perform investor relations services for</em> <em>AdCare Health Systems (<a href='http://seekingalpha.com/symbol/adk' title='Adcare Health Systems Inc'>ADK</a>)</em><em>. Readers should be aware that this compensation may indicate a potential bias in the material presented. The information presented is provided for informational purposes only and is not to be treated as advice to make any specific investment. The content included in this article is based on factual information obtained from public filings and other sources. For our full disclaimer, please visit the link on our</em> <a href="http://seekingalpha.com/author/missionir"><em>profile</em></a><em>.</em></p> <p>Few investment opportunities are sweeter than a turnaround, where the value of a company is increased, sometimes dramatically, through the measured application of superior operational procedures, technologies, or marketing approaches. Usually this involves a single company bringing in new management to make the company more efficient or perhaps point the company in a totally new direction. With big companies, a turnaround can take years, even</p>        <br/><a href='http://seekingalpha.com/article/416831-adcare-health-and-the-art-of-the-turnaround?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/adk">ADK</category>
      <category type="author" link="http://seekingalpha.com/author/missionir">MissionIR</category>
    </item>
    <item>
      <title>VistaGen Therapeutics: A Hidden Stem Cell Opportunity</title>
      <link>http://seekingalpha.com/article/394361-vistagen-therapeutics-a-hidden-stem-cell-opportunity?source=feed</link>
      <guid isPermaLink="false">394361</guid>
      <content>
        <![CDATA[<p>
  <em>Note: We have received monetary compensation to perform investor relations services for VistaGen Therapeutics (<a href='http://seekingalpha.com/symbol/vsta.ob' title='Vistagen Therapeutics Inc.'>VSTA.OB</a>). Readers should be aware that this compensation may indicate a potential bias in the material presented. The information presented is provided for informational purposes only and is not to be treated as advice to make any specific investment. The content included in this article is based on factual information obtained from public filings and other sources. For our full disclaimer, please visit the link on our <a href="http://seekingalpha.com/author/missionir">profile</a>.</em>
</p><p>When it comes to modern medicine, stem cells are seen as playing a role unmatched by anything else. Used in a growing number of cell therapies for certain cancers, various diseases related to the immune system, and other treatment applications, in addition to cell research, stem cell technology is opening an increasing number of doors for medical researchers and practitioners. Today it's a market rapidly closing in</p>]]>
      </content>
      <pubDate>Mon, 27 Feb 2012 09:44:50 -0500</pubDate>
      <author>MissionIR</author>
      <description>
        <![CDATA[<strong>By <a href="http://missionir.com/">MissionIR</a>:</strong><p>
  <em>Note: We have received monetary compensation to perform investor relations services for VistaGen Therapeutics (<a href='http://seekingalpha.com/symbol/vsta.ob' title='Vistagen Therapeutics Inc.'>VSTA.OB</a>). Readers should be aware that this compensation may indicate a potential bias in the material presented. The information presented is provided for informational purposes only and is not to be treated as advice to make any specific investment. The content included in this article is based on factual information obtained from public filings and other sources. For our full disclaimer, please visit the link on our <a href="http://seekingalpha.com/author/missionir">profile</a>.</em>
</p><p>When it comes to modern medicine, stem cells are seen as playing a role unmatched by anything else. Used in a growing number of cell therapies for certain cancers, various diseases related to the immune system, and other treatment applications, in addition to cell research, stem cell technology is opening an increasing number of doors for medical researchers and practitioners. Today it's a market rapidly closing in</p><br/><a href='http://seekingalpha.com/article/394361-vistagen-therapeutics-a-hidden-stem-cell-opportunity?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/vsta.ob">VSTA.OB</category>
      <category type="author" link="http://seekingalpha.com/author/missionir">MissionIR</category>
    </item>
    <item>
      <title>Medical Imaging Stocks</title>
      <link>http://seekingalpha.com/article/321920-medical-imaging-stocks?source=feed</link>
      <guid isPermaLink="false">321920</guid>
      <content>
        <![CDATA[<p>
  <em>Note: We have received monetary compensation to perform investor relations services and increase investor awareness for FluoroPharma Medical &#40;FPMI.OB&#41;. Readers should be aware that this compensation may indicate a potential bias in the material presented. The information presented is provided for informational purposes only and is not to be treated as advice to make any specific investment. The content included in this article is based on factual information obtained from public filings and other sources. For our full disclaimer, please visit the link on our profile.</em>
</p><p>It's almost impossible to overstate the significance of medical imaging in the development of modern medicine. The New England Journal of Medicine, considered the world's oldest and single most influential general medical periodical, calls medical imaging one of the top medical developments of the last millennium. You might say that imaging is to medicine what the telescope is to astronomy. Modern medicine would simply</p>]]>
      </content>
      <pubDate>Wed, 25 Jan 2012 08:37:07 -0500</pubDate>
      <author>MissionIR</author>
      <description>
        <![CDATA[<strong>By <a href="http://missionir.com/">MissionIR</a>:</strong><p>
  <em>Note: We have received monetary compensation to perform investor relations services and increase investor awareness for FluoroPharma Medical &#40;FPMI.OB&#41;. Readers should be aware that this compensation may indicate a potential bias in the material presented. The information presented is provided for informational purposes only and is not to be treated as advice to make any specific investment. The content included in this article is based on factual information obtained from public filings and other sources. For our full disclaimer, please visit the link on our profile.</em>
</p><p>It's almost impossible to overstate the significance of medical imaging in the development of modern medicine. The New England Journal of Medicine, considered the world's oldest and single most influential general medical periodical, calls medical imaging one of the top medical developments of the last millennium. You might say that imaging is to medicine what the telescope is to astronomy. Modern medicine would simply</p><br/><a href='http://seekingalpha.com/article/321920-medical-imaging-stocks?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/ge">GE</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/phg">PHG</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/var">VAR</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tosbf.pk">TOSBF.PK</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ssnlf.pk">SSNLF.PK</category>
      <category type="author" link="http://seekingalpha.com/author/missionir">MissionIR</category>
    </item>
    <item>
      <title>Not All Treasury Securities Are the Same</title>
      <link>http://seekingalpha.com/article/319128-not-all-treasury-securities-are-the-same?source=feed</link>
      <guid isPermaLink="false">319128</guid>
      <content>
        <![CDATA[<p>U.S. Treasury securities have traditionally been considered the safest investments in the world. They are, after all, backed by the “full faith and credit” of the U.S. federal government, a safety net unmatched by any other investment. A company, regardless of its age, size, or reputation, can always fall, sometimes dramatically and unexpectedly. It’s easy to forget that Enron, prior to the financial scandal that led to its bankruptcy in 2001, was a major American corporation, held up as an example of good management. Highlighted multiple times by Fortune as the country’s most innovative company, Enron was dealing in what had been considered a relatively safe foundational part of the economy: electricity, natural gas, and communications. Within a matter of months the $100 billion a year company was no more.</p>  <p>Today, however, with the U.S. and global economy facing a financial crisis like none in history, even the best reputations</p>            ]]>
      </content>
      <pubDate>Thu, 12 Jan 2012 08:52:06 -0500</pubDate>
      <author>MissionIR</author>
      <description>
        <![CDATA[<strong>By <a href="http://missionir.com/">MissionIR</a>:</strong><p>U.S. Treasury securities have traditionally been considered the safest investments in the world. They are, after all, backed by the “full faith and credit” of the U.S. federal government, a safety net unmatched by any other investment. A company, regardless of its age, size, or reputation, can always fall, sometimes dramatically and unexpectedly. It’s easy to forget that Enron, prior to the financial scandal that led to its bankruptcy in 2001, was a major American corporation, held up as an example of good management. Highlighted multiple times by Fortune as the country’s most innovative company, Enron was dealing in what had been considered a relatively safe foundational part of the economy: electricity, natural gas, and communications. Within a matter of months the $100 billion a year company was no more.</p>  <p>Today, however, with the U.S. and global economy facing a financial crisis like none in history, even the best reputations</p>            <br/><a href='http://seekingalpha.com/article/319128-not-all-treasury-securities-are-the-same?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/ltpz">LTPZ</category>
      <category type="author" link="http://seekingalpha.com/author/missionir">MissionIR</category>
    </item>
    <item>
      <title>Tracking The Elusive Gold Nugget Stock: AdCare Health Systems</title>
      <link>http://seekingalpha.com/article/316293-tracking-the-elusive-gold-nugget-stock-adcare-health-systems?source=feed</link>
      <guid isPermaLink="false">316293</guid>
      <content>
        <![CDATA[<p>
  <em>Note: We have received monetary compensation to perform investor relations services and increase investor awareness for </em>
  <em>AdCare Health Systems (<a href='http://seekingalpha.com/symbol/adk' title='Adcare Health Systems Inc'>ADK</a>)</em>
  <em>. Readers should be aware that this compensation may indicate a potential bias in the material presented. The information presented is provided for informational purposes only and is not to be treated as advice to make any specific investment. The content included in this article is based on factual information obtained from public filings and other sources. For our full disclaimer, please visit the link on our </em>
  <a href="http://seekingalpha.com/author/missionir">
    <em>profile</em>
  </a>
  <em>.</em>
</p> <p>One of the classic gold nuggets for an investor is the micro-cap or small-cap company that is just starting to show up on radar screens, but with a strong history of growing revenue, and earnings that appear ready to break into positive territory. It’s a rare combination of qualities, offering investors one of the greatest potentials for substantial, short term profit.</p>       ]]>
      </content>
      <pubDate>Wed, 28 Dec 2011 11:34:13 -0500</pubDate>
      <author>MissionIR</author>
      <description>
        <![CDATA[<strong>By <a href="http://missionir.com/">MissionIR</a>:</strong><p>
  <em>Note: We have received monetary compensation to perform investor relations services and increase investor awareness for </em>
  <em>AdCare Health Systems (<a href='http://seekingalpha.com/symbol/adk' title='Adcare Health Systems Inc'>ADK</a>)</em>
  <em>. Readers should be aware that this compensation may indicate a potential bias in the material presented. The information presented is provided for informational purposes only and is not to be treated as advice to make any specific investment. The content included in this article is based on factual information obtained from public filings and other sources. For our full disclaimer, please visit the link on our </em>
  <a href="http://seekingalpha.com/author/missionir">
    <em>profile</em>
  </a>
  <em>.</em>
</p> <p>One of the classic gold nuggets for an investor is the micro-cap or small-cap company that is just starting to show up on radar screens, but with a strong history of growing revenue, and earnings that appear ready to break into positive territory. It’s a rare combination of qualities, offering investors one of the greatest potentials for substantial, short term profit.</p>       <br/><a href='http://seekingalpha.com/article/316293-tracking-the-elusive-gold-nugget-stock-adcare-health-systems?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/adk">ADK</category>
      <category type="author" link="http://seekingalpha.com/author/missionir">MissionIR</category>
    </item>
    <item>
      <title>6 Noteworthy Small Caps In Traditional Energy</title>
      <link>http://seekingalpha.com/article/310699-6-noteworthy-small-caps-in-traditional-energy?source=feed</link>
      <guid isPermaLink="false">310699</guid>
      <content>
        <![CDATA[<p>In spite of the precarious nature of the global economy, with still unresolved (some would say unaddressed) debt crises in Europe and the U.S., now joined by a growing concern that China’s real estate market is just the latest bubble about to burst, the energy sector, primarily oil and gas, continues to hold its own. In September, Moody’s had cut the sector’s outlook to “stable” on expectations of softening crude oil prices and tighter refining profit margins, but investors hardly took note. Perhaps of more significance is the ongoing development of shale gas resources, natural gas produced from shale. Shale gas appears destined for a big role in American energy, with major deposits in Canada and the U.S.</p> <p>How all of these factors will ultimately play out is impossible to say, but energy sector stocks are still considered by many to play a critical part in a healthy stock portfolio.</p>                               ]]>
      </content>
      <pubDate>Tue, 29 Nov 2011 08:24:28 -0500</pubDate>
      <author>MissionIR</author>
      <description>
        <![CDATA[<strong>By <a href="http://missionir.com/">MissionIR</a>:</strong><p>In spite of the precarious nature of the global economy, with still unresolved (some would say unaddressed) debt crises in Europe and the U.S., now joined by a growing concern that China’s real estate market is just the latest bubble about to burst, the energy sector, primarily oil and gas, continues to hold its own. In September, Moody’s had cut the sector’s outlook to “stable” on expectations of softening crude oil prices and tighter refining profit margins, but investors hardly took note. Perhaps of more significance is the ongoing development of shale gas resources, natural gas produced from shale. Shale gas appears destined for a big role in American energy, with major deposits in Canada and the U.S.</p> <p>How all of these factors will ultimately play out is impossible to say, but energy sector stocks are still considered by many to play a critical part in a healthy stock portfolio.</p>                               <br/><a href='http://seekingalpha.com/article/310699-6-noteworthy-small-caps-in-traditional-energy?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/cnep.pk">CNEP.PK</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/lgcy">LGCY</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/apagf">APAGF</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/clmt">CLMT</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/atw">ATW</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/bbep">BBEP</category>
      <category type="author" link="http://seekingalpha.com/author/missionir">MissionIR</category>
    </item>
    <item>
      <title>VistaGen Therapeutics Represents Growing Field Of Cell-Based Therapy</title>
      <link>http://seekingalpha.com/article/307232-vistagen-therapeutics-represents-growing-field-of-cell-based-therapy?source=feed</link>
      <guid isPermaLink="false">307232</guid>
      <content>
        <![CDATA[<p>
  <em>
    <span>Note: We have received monetary compensation to perform investor relations services and increase investor awareness for VistaGen Therapeutics (<a href='http://seekingalpha.com/symbol/vsta.ob' title='Vistagen Therapeutics Inc.'>VSTA.OB</a>). Readers should be aware that this compensation may indicate a potential bias in the material presented. The information presented is provided for informational purposes only and is not to be treated as advice to make any specific investment. The content included in this article is based on factual information obtained from public filings and other sources. For our full disclaimer, please visit the link on our <a href="http://seekingalpha.com/author/missionir">profile</a>.</span>
  </em>
</p> <p>Few would dispute the fact that more progress has been made in medicine and the overall science of healthcare in the past century than in all of the previous centuries put together. If there’s a focal point for this ongoing revolution, it’s the increasing ability to treat disease at the cellular and even molecular level, often through tapping the patient’s own</p>     ]]>
      </content>
      <pubDate>Fri, 11 Nov 2011 05:42:15 -0500</pubDate>
      <author>MissionIR</author>
      <description>
        <![CDATA[<strong>By <a href="http://missionir.com/">MissionIR</a>:</strong><p>
  <em>
    <span>Note: We have received monetary compensation to perform investor relations services and increase investor awareness for VistaGen Therapeutics (<a href='http://seekingalpha.com/symbol/vsta.ob' title='Vistagen Therapeutics Inc.'>VSTA.OB</a>). Readers should be aware that this compensation may indicate a potential bias in the material presented. The information presented is provided for informational purposes only and is not to be treated as advice to make any specific investment. The content included in this article is based on factual information obtained from public filings and other sources. For our full disclaimer, please visit the link on our <a href="http://seekingalpha.com/author/missionir">profile</a>.</span>
  </em>
</p> <p>Few would dispute the fact that more progress has been made in medicine and the overall science of healthcare in the past century than in all of the previous centuries put together. If there’s a focal point for this ongoing revolution, it’s the increasing ability to treat disease at the cellular and even molecular level, often through tapping the patient’s own</p>     <br/><a href='http://seekingalpha.com/article/307232-vistagen-therapeutics-represents-growing-field-of-cell-based-therapy?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/astm">ASTM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/btx">BTX</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cytx">CYTX</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/bone">BONE</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/psti">PSTI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/gern">GERN</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cur">CUR</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/nbs">NBS</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/actc.ob">ACTC.OB</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/vsta.ob">VSTA.OB</category>
      <category type="author" link="http://seekingalpha.com/author/missionir">MissionIR</category>
    </item>
    <item>
      <title>7 Notable Diversified Small-Cap Dividend Stocks</title>
      <link>http://seekingalpha.com/article/306119-7-notable-diversified-small-cap-dividend-stocks?source=feed</link>
      <guid isPermaLink="false">306119</guid>
      <content>
        <![CDATA[<p>Instead of relying on equity growth during times of economic uncertainty, investors are understandably taking a closer look at dividend stocks as a way to buffer share price risks. Not only do dividends offer a straightforward return, dividend paying stocks have a significantly better record of equity growth than non-dividend stocks.  Companies are generally reluctant to suspend dividends, and the predictability of an ensured return means a lot in the marketplace, especially during troubled times. It’s a coupling of cash flow and capital gains that every investor needs to consider as part of a robust portfolio.</p><p>An investor can add to this the advantages offered by small-cap stocks, such as the increased chance for more aggressive growth represented by smaller more flexible companies offering unique products and services that are new to the marketplace. The problem is that small caps are far less likely to offer dividends, preferring to use</p>]]>
      </content>
      <pubDate>Tue, 08 Nov 2011 10:06:33 -0500</pubDate>
      <author>MissionIR</author>
      <description>
        <![CDATA[<strong>By <a href="http://missionir.com/">MissionIR</a>:</strong><p>Instead of relying on equity growth during times of economic uncertainty, investors are understandably taking a closer look at dividend stocks as a way to buffer share price risks. Not only do dividends offer a straightforward return, dividend paying stocks have a significantly better record of equity growth than non-dividend stocks.  Companies are generally reluctant to suspend dividends, and the predictability of an ensured return means a lot in the marketplace, especially during troubled times. It’s a coupling of cash flow and capital gains that every investor needs to consider as part of a robust portfolio.</p><p>An investor can add to this the advantages offered by small-cap stocks, such as the increased chance for more aggressive growth represented by smaller more flexible companies offering unique products and services that are new to the marketplace. The problem is that small caps are far less likely to offer dividends, preferring to use</p><br/><a href='http://seekingalpha.com/article/306119-7-notable-diversified-small-cap-dividend-stocks?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/jcs">JCS</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/hwkn">HWKN</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/kbalb">KBALB</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/mmlp">MMLP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/nhc">NHC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/nrci">NRCI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/saft">SAFT</category>
      <category type="author" link="http://seekingalpha.com/author/missionir">MissionIR</category>
    </item>
    <item>
      <title>Great Depression 2.0 Is Not The Original</title>
      <link>http://seekingalpha.com/article/302672-great-depression-2-0-is-not-the-original?source=feed</link>
      <guid isPermaLink="false">302672</guid>
      <content>
        <![CDATA[<p>When, in recent months, television viewers were treated to scenes of mile high dust storms rolling across parts of Texas and Arizona, the eerie sense of history repeating itself was inevitable and widespread. Even a decade ago, such events would not have been so quick to conjure up comparisons with the Dust Bowl of the 1930s and the Great Depression. In the context of today’s economic turmoil, it’s unavoidable.</p> <p>Nobody suggests that the economic structure, along with the systems and technologies that support it, are the same now as they were at the outset of the Great Depression in 1929. Instead the concern seems to be that there could be some sort of larger underlying principles, lessons not learned, driving America, and perhaps the world, down a catastrophic path uncomfortably parallel to the past. Not lost in the comparison is the fact that the county’s greatest depression also ended in</p>]]>
      </content>
      <pubDate>Thu, 27 Oct 2011 09:10:04 -0400</pubDate>
      <author>MissionIR</author>
      <description>
        <![CDATA[<strong>By <a href="http://missionir.com/">MissionIR</a>:</strong><p>When, in recent months, television viewers were treated to scenes of mile high dust storms rolling across parts of Texas and Arizona, the eerie sense of history repeating itself was inevitable and widespread. Even a decade ago, such events would not have been so quick to conjure up comparisons with the Dust Bowl of the 1930s and the Great Depression. In the context of today’s economic turmoil, it’s unavoidable.</p> <p>Nobody suggests that the economic structure, along with the systems and technologies that support it, are the same now as they were at the outset of the Great Depression in 1929. Instead the concern seems to be that there could be some sort of larger underlying principles, lessons not learned, driving America, and perhaps the world, down a catastrophic path uncomfortably parallel to the past. Not lost in the comparison is the fact that the county’s greatest depression also ended in</p><br/><a href='http://seekingalpha.com/article/302672-great-depression-2-0-is-not-the-original?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/iau">IAU</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/erx">ERX</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/spy">SPY</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/sbm">SBM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/vbk">VBK</category>
      <category type="author" link="http://seekingalpha.com/author/missionir">MissionIR</category>
    </item>
    <item>
      <title>5 Financial Service Small Caps With Dynamite Growth And Earnings</title>
      <link>http://seekingalpha.com/article/300271-5-financial-service-small-caps-with-dynamite-growth-and-earnings?source=feed</link>
      <guid isPermaLink="false">300271</guid>
      <content>
        <![CDATA[<p>Few business sectors have ever had to face the wrath currently being directed at Financial Services. As demonstrators continue to take to the streets across the country, decrying Wall Street bailouts, corporate greed, and all of the foreclosures, unemployment, and other pain that they are argued to have caused, it’s an industry vilified as none in recent history. Fueled by a common animosity, and made possible largely by the real-time world of social communications, the protests represent a distance between power and the people reminiscent of the revolutionary case against King George.</p>  <p>And yet, as if to emphasize the disconnect, several large banks have chosen now as a good time to impose new debit card fees, perhaps as a thumb in the eye of the Obama administration and the Dodd-Frank bill passed in 2010 that restricted fees banks could charge merchants for debit card usage. It can be argued that</p>                ]]>
      </content>
      <pubDate>Tue, 18 Oct 2011 11:15:58 -0400</pubDate>
      <author>MissionIR</author>
      <description>
        <![CDATA[<strong>By <a href="http://missionir.com/">MissionIR</a>:</strong><p>Few business sectors have ever had to face the wrath currently being directed at Financial Services. As demonstrators continue to take to the streets across the country, decrying Wall Street bailouts, corporate greed, and all of the foreclosures, unemployment, and other pain that they are argued to have caused, it’s an industry vilified as none in recent history. Fueled by a common animosity, and made possible largely by the real-time world of social communications, the protests represent a distance between power and the people reminiscent of the revolutionary case against King George.</p>  <p>And yet, as if to emphasize the disconnect, several large banks have chosen now as a good time to impose new debit card fees, perhaps as a thumb in the eye of the Obama administration and the Dodd-Frank bill passed in 2010 that restricted fees banks could charge merchants for debit card usage. It can be argued that</p>                <br/><a href='http://seekingalpha.com/article/300271-5-financial-service-small-caps-with-dynamite-growth-and-earnings?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/afsi">AFSI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ezpw">EZPW</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/fcfs">FCFS</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tcbi">TCBI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/wrld">WRLD</category>
      <category type="author" link="http://seekingalpha.com/author/missionir">MissionIR</category>
    </item>
    <item>
      <title>Green Energy's Bottom Line</title>
      <link>http://seekingalpha.com/article/296885-green-energy-s-bottom-line?source=feed</link>
      <guid isPermaLink="false">296885</guid>
      <content>
        <![CDATA[<p>It goes without saying: If you want to start an argument, bring up the issue of green (renewable) energy. Exactly how many different opinions there are is uncertain, but it’s clearly more than the total number of solar panels and windmills. In spite of the growing number of green energy startups and government programs supporting them (recently failed Solyndra being the current hot topic), there’s little agreement on when, or if, green energy will play the majority role in world energy production. Just how far have we come, and where are we now?</p>   <p>The green energy movement has been around for longer than most people think. Although part of the larger environmental movement, which has long historical roots, the green energy movement can be traced back to the late 1800s, when science first began to suspect that increased CO<sub>2</sub> levels, caused by human activities, could eventually result in</p>                                                  ]]>
      </content>
      <pubDate>Fri, 30 Sep 2011 12:21:33 -0400</pubDate>
      <author>MissionIR</author>
      <description>
        <![CDATA[<strong>By <a href="http://missionir.com/">MissionIR</a>:</strong><p>It goes without saying: If you want to start an argument, bring up the issue of green (renewable) energy. Exactly how many different opinions there are is uncertain, but it’s clearly more than the total number of solar panels and windmills. In spite of the growing number of green energy startups and government programs supporting them (recently failed Solyndra being the current hot topic), there’s little agreement on when, or if, green energy will play the majority role in world energy production. Just how far have we come, and where are we now?</p>   <p>The green energy movement has been around for longer than most people think. Although part of the larger environmental movement, which has long historical roots, the green energy movement can be traced back to the late 1800s, when science first began to suspect that increased CO<sub>2</sub> levels, caused by human activities, could eventually result in</p>                                                  <br/><a href='http://seekingalpha.com/article/296885-green-energy-s-bottom-line?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/bwen">BWEN</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/satc">SATC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/gtat">GTAT</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/spwr">SPWR</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/pzd">PZD</category>
      <category type="author" link="http://seekingalpha.com/author/missionir">MissionIR</category>
    </item>
    <item>
      <title>VistaGen Therapeutics' Potential Rewards Far Exceed Its Current Market Valuation</title>
      <link>http://seekingalpha.com/article/295869-vistagen-therapeutics-potential-rewards-far-exceed-its-current-market-valuation?source=feed</link>
      <guid isPermaLink="false">295869</guid>
      <content>
        <![CDATA[<div><em><span>Note: MissionIR has received monetary compensation to perform investor relations services and increase investor awareness for VistaGen Therapeutics (<a href='http://seekingalpha.com/symbol/vsta.ob' title='Vistagen Therapeutics Inc.'>VSTA.OB</a>). Readers should be aware that this compensation may indicate a potential bias in the material presented. The information presented is provided for informational purposes only and is not to be treated as advice to make any specific investment. The content included in this article is based on factual information obtained from public filings and other sources. For our full disclaimer, please visit the link on our <a href="http://seekingalpha.com/author/missionir">profile</a>.</span></em><br/><br/>The good news is that new pharmaceutical discoveries are being made nearly every day for the treatment of life threatening diseases. The bad news is that, after hundreds of millions of dollars spent to identify and develop these potential lifesavers, they often never make it to market. Lives may hang in the balance, but it makes little difference when promising new drugs are</div>]]>
      </content>
      <pubDate>Mon, 26 Sep 2011 08:52:48 -0400</pubDate>
      <author>MissionIR</author>
      <description>
        <![CDATA[<strong>By <a href="http://missionir.com/">MissionIR</a>:</strong><div><em><span>Note: MissionIR has received monetary compensation to perform investor relations services and increase investor awareness for VistaGen Therapeutics (<a href='http://seekingalpha.com/symbol/vsta.ob' title='Vistagen Therapeutics Inc.'>VSTA.OB</a>). Readers should be aware that this compensation may indicate a potential bias in the material presented. The information presented is provided for informational purposes only and is not to be treated as advice to make any specific investment. The content included in this article is based on factual information obtained from public filings and other sources. For our full disclaimer, please visit the link on our <a href="http://seekingalpha.com/author/missionir">profile</a>.</span></em><br/><br/>The good news is that new pharmaceutical discoveries are being made nearly every day for the treatment of life threatening diseases. The bad news is that, after hundreds of millions of dollars spent to identify and develop these potential lifesavers, they often never make it to market. Lives may hang in the balance, but it makes little difference when promising new drugs are</div><br/><a href='http://seekingalpha.com/article/295869-vistagen-therapeutics-potential-rewards-far-exceed-its-current-market-valuation?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/vsta.ob">VSTA.OB</category>
      <category type="author" link="http://seekingalpha.com/author/missionir">MissionIR</category>
    </item>
  </channel>
</rss>
